REQUEST A DEMO
Total
USD $0.00
Search more companies

Microbio Co., Ltd. (Taiwan, China)

Main Activities: Medicinal and Botanical Manufacturing
Full name: Microbio Co., Ltd. Profile Updated: May 24, 2024
Buy our report for this company USD 29.95 Most recent financial data: 2023 Available in: English & Chinese Download a sample report

Microbio Co., Ltd. was established in 1989, went public in 1990 and went listed in OTC market in 1995. In July 1995, it set up its own direct sales business Daigo clear, entering the direct market. In January 1996 its new plant drug MS-20 was approved by the FDA for Phase II human clinical trials. Microbio Co., Ltd. has got its main annual revenue relying on health food; its strategy is to maintain the development of new drugs with the income from health food sales.

Headquarters
14F-1,No.3, Yuan Qu St
Taipei City; Taipei City;

Contact Details: Purchase the Microbio Co., Ltd. report to view the information.

Website: http://twmicrobio.com

Basic Information
Total Employees:
Purchase the Microbio Co., Ltd. report to view the information.
Outstanding Shares:
Purchase the Microbio Co., Ltd. report to view the information.
Financial Auditors:
Purchase the Microbio Co., Ltd. report to view the information.
Incorporation Date:
May 03, 2000
Key Executives
Purchase this report to view the information.
Chairman
Purchase this report to view the information.
Vice President
Ownership Details
Purchase this report to view the information.
8.11%
Purchase this report to view the information.
Purchase this report to view the information.
Purchase this report to view the information.
Purchase this report to view the information.
Subsidiaries
中天健康事業股份有限公司
100%
棉花田生機園地股份有限公司
72.66%
Microbio Pharmaceutical Co Ltd
50.34%
Company Performance
Financial values in the chart are available after Microbio Co., Ltd. report is purchased.
Looking for more than just a company report?

EMIS company profiles are part of a larger information service which combines company, industry and country data and analysis for over 145 emerging markets.

Request a demo of the EMIS service
Key Financial Highlights
Annual growth percentages for latest two years in local currency TWD. Absolute financial data is included in the purchased report.
Net sales revenue
8.62%
Total operating revenue
-31.47%
Operating profit (EBIT)
-88.7%
EBITDA
26.06%
Net Profit (Loss) for the Period
29.37%
Total assets
-1.29%
Total equity
-2.43%
Operating Profit Margin (ROS)
-28.04%
Net Profit Margin
32.06%
Return on Equity (ROE)
1.45%
Quick Ratio
-1.59%
Cash Ratio
-0.15%

To view more information, Request a demonstration of the EMIS service

Buy this company report
Need ongoing access to company, industry or country information?